Treatment of scalp angiosarcoma by controlled perfusion of A. carotis externa with pegylated liposomal doxorubicin and intralesional application of pegylated interferon alfa

Journal of the American Academy of Dermatology

Volumn 52, Issue 2 SUPPL., 2005, Pages

  Bong, Anne B ^a   Bonnekoh, Bernd ^a   Schön, Michael Peter ^a   Gollnick, Harald ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PEGINTERFERON ALPHA2B;

AGED; ANEMIA; ANGIOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DOSE RESPONSE; EDEMA; ERYTHEMA; EXTERNAL CAROTID ARTERY; FOREHEAD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; MALE; PERFUSION; PRIORITY JOURNAL; SCALP ANGIOSARCOMA; SIDE EFFECT; SKIN DEFECT; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAROTID ARTERY, EXTERNAL; DOXORUBICIN; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2B; LIPOSOMES; MALE; SCALP; SKIN NEOPLASMS;

EID: 12844287597     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.06.026     Document Type: Article

References (15)

1. R. Fink-Puches, J. Smolle, A. Beham, H. Kerl, and H.P. Soyer Kutane Angiosarkome Hautarzt 51 2000 479 485
2. R.J. Mark, J.C. Poen, and L.M. Tran Angiosarcoma: a report of 67 patients and a review of the literature Cancer 77 1996 2400 2406
3. A. Verleysen, K. Dewolf, M.L. Geerts, and J.M. Naeyaert Angiosarcoma of the face and scalp Eur J Dermatol 10 2000 403 404
4. W.H. Morrison, R.M. Byers, A.S. Garden, H.L. Evans, K.K. Ang, and L.J. Peters Cutaneous angiosarcoma of the head and neck: a therapeutic dilemma Cancer 76 1995 319 327
5. J. Ulrich, M. Krause, A. Brachmann, I. Franke, and H. Gollnick Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation J Eur Acad Dermatol Venereol 14 2000 412 415
6. K. Spieth, J. Gille, and R. Kaufmann Therapeutic efficacy of interferon- and 13-cis-retinoic acid in recurrent angiosarcomas of the head Arch Dermatol 135 1999 1035 1037
7. F.D. Goebel, D. Goldstein, M. Goos, H. Jablonowski, and J.S. Stewart Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma Br J Cancer 73 1996 989 994
8. A. Jackel, M. Deichmann, V. Waldmann, M. Bock, and H. Naher Regression of metastatic agiosarcoma of the skin after systemic treatment with liposome-encapsulated doxorubicin and interferon-alpha Br J Dermatol 140 1999 1187 1188
9. D.W. Northfelt, B.J. Dezube, J.A. Thommes, B.J. Miller, M.A. Fischl, and A. Friedman-Kein Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial J Clin Oncol 16 1998 2445 2451
10. S. Eiling, S. Lischner, J.O. Busch, D. Rothaupt, E. Christophers, and A. Hauschild Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin Br J Dermatol 147 2002 150 153
11. H.M. Ockenfels, N.H. Brockmeyer, U. Hengge, and M. Goos Cutaneous angiosarcoma: a novel therapy with liposomal doxorubicin? J Eur Acad Dermatol Venereol 6 1996 71 75
12. U. Wollina, T. Graefe, and K. Karte Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin J Am Acad Dermatol 42 2000 40 46
13. D. Papahadipoulos, T.M. Allen, A. Gabizone, E. Mayhew, K. Matthay, and S.K. Huang Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc Natl Acad Sci U S A 88 1991 11460 11464
14. P.K. Working, and A.D. Dayan Pharmacological-toxicological expert report: Caelyx (stealth liposomal doxorubicin HCL) Hum Exp Toxicol 15 1996 752 785
15. K.B. Gordon, A. Tajuddin, J. Guitart, T.M. Kuzel, L.R. Eramo, and J. Vonroen Hand-foot syndrome associated with liposomal-encapsulated doxorubicin therapy Cancer 75 1995 2169 2173